Skip to main content
. 2016 Sep 13;4(9):2325967116665595. doi: 10.1177/2325967116665595

Table 4.

General Blood Test Resultsa

Variable PRP Group Control Group Statistics
WBC count, ×109/L
 Preop 6.5 ± 1.50 6.28 ± 1.84 t = 0.62, P = .54
 6 weeks postop 6.8 ± 1.86 6.41 ± 1.72 t = 0.97, P = .34
Hemoglobin (Hb), g/L
 Preop 142.8 ± 10 143.3 ± 14 t = 0.18, P = .86
 6 weeks postop 144.4 ± 9 143.2 ± 12 t = 0.48, P = .63
Hematocrit
 Preop 0.42 ± 0.03 0.43 ± 0.04 t = 0.18, P = .86
 6 weeks postop 0.42 ± 0.03 0.43 ± 0.05 t = 0.74, P = .46
Platelet count, ×109/L
 Preop 231.5 ± 65 245 ± 61 t = 0.96, P = .34
 6 weeks postop 235.1 ± 55 243.9 ± 65 t = 0.63, P = .53
A1c (HbA1c), %
 Preop 5.5 ± 0.03 5.5 ± 0.03 t = 1.64, P = .10
 6 weeks postop 5.8 ± 0.07 5.7 ± 0.06 t = 1.64, P = .10
C-reactive protein
 Preop 2.35 ± 2.5 2.70 ± 2.96 t = 1.21, P = .23
 6 weeks postop 2.51 ± 2.7 3.37 ± 3.4 t = 0.53, P = .60
Partial thromboplastin time, s
 Preop 30.65 ± 3 30.46 ± 2 t = 0.31, P = .75
 6 weeks postop 31.21 ± 3 31.17 ± 2 t = 0.06, P = .95

aData are presented as mean ± SD. Hb, hemoglobin; HbA1c, glycated hemoglobin; postop, postoperative; preop, preoperative; PRP, platelet-rich plasma; WBC, white blood cell.